Biomarker for Cancer
Clinical Applications and Research
We’re excited to bring you the newest Growing Body of Evidence: Thymidine Kinase.
Research in support of TK1 as a biomarker for cancer detection and monitoring continues to mount. The Growing Body of Evidence provides a summary of that research, and applications for use in your practice.
Click to download, or learn more below.
TK1 is available in the following tests/panels from VDI:
- Wellness Panels + Cancer Risk
- Canine Cancer Panel
- Pericardial Effusion Panel (PCE)
- Feline Cancer Panel
- Pre-Stem Cell Therapy Panel
- Equine TK1
CLINICAL APPLICATIONS
Canine:
- Lymphoma
- Abdominal Masses
- Hypercalcemia of malignancy
- ADR
- Stem Cell Therapy
- Metastatic Disease
- Therapeutic Monitoring
- Pericardial Effusion Tumor Dx
- Wellness Screening
Feline:
- GI Lymphoma vs IBD
- Therapeutic Monitoring
- Metastatic Disease
Equine:
- Lymphoma